|
Redwoods Acquisition Corp (NASDAQ: RWODU) |
|
Redwoods Acquisition Corp
RWODU's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Redwoods Acquisition's sales fell
in III. Quarter 2024 from the same quarter a year ago.
Biotechnology & Pharmaceuticals industry recorded
growth of revenues by 13.31 %
Redwoods Acquisition net loss increased from $0 millions, to $-3 millions in III. Quarter 2024,
• More on RWODU's Growth
|
|
Redwoods Acquisition realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 1829.44 in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.66.
• More on RWODU's Valuation
|
|
|
|
|
Redwoods Acquisition realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 1829.44 in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.66.
Redwoods Acquisition Price to Book Ratio is at 88.55 lower than Industry Avg. of 405.85. and higher than S&P 500 Avg. of 0.01
• More on RWODU's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com